0001193125-22-198474.txt : 20220721 0001193125-22-198474.hdr.sgml : 20220721 20220721070107 ACCESSION NUMBER: 0001193125-22-198474 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 12 CONFORMED PERIOD OF REPORT: 20220720 ITEM INFORMATION: Other Events FILED AS OF DATE: 20220721 DATE AS OF CHANGE: 20220721 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Verve Therapeutics, Inc. CENTRAL INDEX KEY: 0001840574 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 824800132 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-40489 FILM NUMBER: 221095544 BUSINESS ADDRESS: STREET 1: 500 TECHNOLOGY SQUARE CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: (978) 501-3026 MAIL ADDRESS: STREET 1: 500 TECHNOLOGY SQUARE CITY: CAMBRIDGE STATE: MA ZIP: 02139 8-K 1 d354954d8k.htm 8-K 8-K
false 0001840574 0001840574 2022-07-20 2022-07-20

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d)

OF THE SECURITIES EXCHANGE ACT OF 1934

Date of Report (Date of earliest event reported): July 20, 2022

 

 

Verve Therapeutics, Inc.

(Exact name of registrant as specified in its charter)

 

 

 

Delaware   001-40489   82-4800132
(State or Other Jurisdiction
of Incorporation)
 

(Commission

File Number)

 

(IRS Employer

Identification No.)

 

500 Technology Square, Suite 901

Cambridge, Massachusetts

  02139
(Address of Principal Executive Offices)   (Zip Code)

Registrant’s telephone number, including area code: (617) 603-0070

Not applicable

(Former Name or Former Address, if Changed Since Last Report)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class

 

Trading

symbol(s)

 

Name of each exchange

on which registered

Common stock, $0.001 par value per share   VERV   Nasdaq Global Select Market

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company  

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  

 

 

 


Item 8.01

Other Events.

On July 20, 2022, Verve Therapeutics, Inc. (the “Company”) delivered a written notice to Jefferies LLC (“Jefferies”) that it was suspending and terminating the prospectus (the “ATM Prospectus”) related to the sale of its common stock, $0.001 par value per share (the “Common Stock”) in an “at-the-market” offering pursuant to the terms of the Open Market Sale AgreementSM, dated July 1, 2022 (the “Sales Agreement”) by and between the Company and Jefferies. The Company will not make any sales of its Common Stock pursuant to the Sales Agreement unless and until a new prospectus, prospectus supplement or registration statement is filed. The Sales Agreement remains in full force and effect. As of July 20, 2022, the Company had not issued and sold any shares of its Common Stock under the ATM Prospectus.

A copy of the Sales Agreement was filed as Exhibit 1.2 to the Company’s Registration Statement on Form S-3 (333-265996), which was originally filed with the Securities and Exchange Commission on July 1, 2022.


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

    VERVE THERAPEUTICS, INC.
Date: July 21, 2022     By:  

/s/ Allison Dorval

    Name:   Allison Dorval
    Title:   Chief Financial Officer
EX-101.SCH 2 verv-20220720.xsd XBRL TAXONOMY EXTENSION SCHEMA 100000 - Document - Document and Entity Information link:calculationLink link:presentationLink link:definitionLink EX-101.LAB 3 verv-20220720_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE Cover [Abstract] Cover [Abstract] Amendment Flag Amendment Flag Entity Central Index Key Entity Central Index Key Document Type Document Type Document Period End Date Document Period End Date Entity Registrant Name Entity Registrant Name Entity Incorporation State Country Code Entity Incorporation State Country Code Entity File Number Entity File Number Entity Tax Identification Number Entity Tax Identification Number Entity Address, Address Line One Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Two Entity Address, City or Town Entity Address, City or Town Entity Address, State or Province Entity Address, State or Province Entity Address, Postal Zip Code Entity Address, Postal Zip Code City Area Code City Area Code Local Phone Number Local Phone Number Written Communications Written Communications Soliciting Material Soliciting Material Pre Commencement Tender Offer Pre Commencement Tender Offer Pre Commencement Issuer Tender Offer Pre Commencement Issuer Tender Offer Security 12b Title Security 12b Title Trading Symbol Trading Symbol Security Exchange Name Security Exchange Name Entity Emerging Growth Company Entity Emerging Growth Company Entity Ex Transition Period Entity Ex Transition Period EX-101.PRE 4 verv-20220720_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE XML 5 R1.htm IDEA: XBRL DOCUMENT v3.22.2
Document and Entity Information
Jul. 20, 2022
Cover [Abstract]  
Amendment Flag false
Entity Central Index Key 0001840574
Document Type 8-K
Document Period End Date Jul. 20, 2022
Entity Registrant Name Verve Therapeutics, Inc.
Entity Incorporation State Country Code DE
Entity File Number 001-40489
Entity Tax Identification Number 82-4800132
Entity Address, Address Line One 500 Technology Square
Entity Address, Address Line Two Suite 901
Entity Address, City or Town Cambridge
Entity Address, State or Province MA
Entity Address, Postal Zip Code 02139
City Area Code (617)
Local Phone Number 603-0070
Written Communications false
Soliciting Material false
Pre Commencement Tender Offer false
Pre Commencement Issuer Tender Offer false
Security 12b Title Common stock, $0.001 par value per share
Trading Symbol VERV
Security Exchange Name NASDAQ
Entity Emerging Growth Company true
Entity Ex Transition Period false
XML 6 d354954d8k_htm.xml IDEA: XBRL DOCUMENT 0001840574 2022-07-20 2022-07-20 false 0001840574 8-K 2022-07-20 Verve Therapeutics, Inc. DE 001-40489 82-4800132 500 Technology Square Suite 901 Cambridge MA 02139 (617) 603-0070 false false false false Common stock, $0.001 par value per share VERV NASDAQ true false EXCEL 7 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx M4$L#!!0 ( " X]50'04UB@0 +$ 0 9&]C4')O<',O87!P+GAM M;$V./0L",1!$_\IQO;=!P4)B0-!2L+(/>QLOD&1#LD)^OCG!CVX>;QA&WPIG M*N*I#BV&5(_C(I(/ !47BK9.7:=N')=HI6-Y #OGDK7A.YNJQ<&4GPZ4A!0W_J=0U[R;UEA_6\#MI7E!+ P04 M " @./54O/(?,.X K @ $0 &1O8U!R;W!S+V-O&ULS9)- M:L,P$$:O4K2W1W*@!>%XDY)5"H4&6KH3TB01M7Z0IMBY?64W<2CM 0K::.;3 MFS>@5D>I0\+G%"(FLICO1M?[+'5$+\U#2$Y1N:8C1*4_ MU!&AX?P>')(RBA1,P"HN1-:U1DN=4%%(%[S1"SY^IGZ&&0W8HT-/&40M@'73 MQ'@>^Q9N@ E&F%S^+J!9B'/U3^S< 79)CMDNJ6$8ZF$UY\H. MZ>=B_SNI7U MF9376%YE*^D<<3G\?7+]X7<3=L'8@_W' MQE?!KH5?_Z+[ E!+ P04 " @./54F5R<(Q & "<)P $P 'AL+W1H M96UE+W1H96UE,2YX;6SM6EMSVC@4?N^OT'AG]FT+QC:!MK03621A'^_1S80RY8-[9)-NIL\!"SI^\Y%1^?H.'GS[BYBZ(:(E/)X M8-DOV]:[MR_>X%#BVR]*+ M41B1%G\@M MNN01.+5)#3(3/PB=AIAJ4!P"I DQEJ&&^+3&K!'@$WVWO@C(WXV(]ZMOFCU7 MH5A)VH3X$$8:XIQSYG/1;/L'I4;1]E6\W*.76!4!EQC?-*HU+,76>)7 \:V< M/!T3$LV4"P9!AI@S M&L%&KQMUAVC2/'K^!?F<-0HACA*FNVB<5@$_9Y>PTG!Z(++9OVX?H;5,VPLCO='U!=*Y \FIS_I,C0' MHYI9";V$5FJ?JH,@H%\;D>/N5Z> HWEL:\4*Z">P'_T=HWPJOX@L Y M?RY]SZ7ON?0]H=*W-R-]9\'3BUO>1FY;Q/NN,=K7-"XH8U=RSTS0LS0[=R2^JVE+ZU)CA* M]+',<$X>RPP[9SR2';9WH!TU^_9==N0CI3!3ET.X&D*^ VVZG=PZ.)Z8D;D* MTU*0;\/YZ<5X&N(YV02Y?9A7;>?8T='[Y\%1L*/O/)8=QXCRHB'NH8:8S\-# MAWE[7YAGE<90-!1M;*PD+$:W8+C7\2P4X&1@+: '@Z]1 O)256 Q6\8#*Y"B M?$R,1>APYY=<7^/1DN/;IF6U;J\I=QEM(E(YPFF8$V>KRMYEL<%5'<]56_*P MOFH]M!5.S_Y9KF4Q9Z;RWRT,"2Q;B%D2XDU=[=7GFYRN>B)V^I=W MP6#R_7#)1P_E.^=?]%U#KG[VW>/Z;I,[2$R<><41 71% B.5' 86%S+D4.Z2 MD 83 >LX=SFWJXPD6L_UC6'ODRWSEPVSK> U[F M$RQ#I'[!?8J*@!&K8KZZKT_Y)9P[M'OQ@2";_-;;I/;=X Q\U*M:I60K$3]+ M!WP?D@9CC%OT-%^/%&*MIK&MQMHQ#'F 6/,,H68XWX=%FAHSU8NL.8T*;T'5 M0.4_V]0-:/8--!R1!5XQF;8VH^1."CS<_N\-L,+$CN'MB[\!4$L#!!0 ( M " X]50UC.EN@P0 ,X1 8 >&PO=V]R:W-H965T&UL MC9AO<^(V$,:_BL:]Z;0S22P; B0%9@A)KNE=_[1:/2M[N)'J54><&[)-XE2/G,B8[-IU=1#QA.D+F?$4 M[JRD2IB!4[5V=:8X"XM.2>SZE/;+SR+=63L!7<\S-B:S[GY*YLI.',KE5 D/-5"ID3QU-0A'#K5$/.:!L1(,?M[XE,>Q50*.;WM1IWJF[7AX M_*Y^7PP>!K-DFD]E_%6$)AHY X>$?,7RV#S+S>]\/Z!+JQ?(6!?_R:9LVZ4. M"7)M9++O# 2)2,M?MMT'XK"#=Z2#O^_@%]SE@PK*6V;8>*CDABC;&M3L03'4 MHC? B=3.RMPHN"N@GQG?RB"'(!O"TI#!K0+T*T"_T.LI^#J8^G@"T0N+"-[';-U$A_=? ML5ASA*-;<711G?W<38%$L1CF,.1;\HGOFHAP)4JI-^C2RWX7P;JLL"Y1L2J_ M%KN,-['@W0?GGQ"(7@71.PUBQI60-L]# JNED0=7JK*[+;W[%5K_E&E[YFMA M$QP8GUC2"(;KO-BT)HN(*Y;QW(A GT$.!!<(XJ!"')R""&I295(5OD#F!N)' MIC*'=(.LDV$C,RY\>X?0755T5Z?0W8N8DZ<\67+5!()K0,*?=VEW<(7P>+1V M5'H*T8)MR4,(62=6(BB#=IRO17+@GW<'0-G!4LX[\'SO%,))&((?0J+L#\AG M:$>^I(U3V2)Y22E9\"!*92S7.S+_EC.%V9I7^[^'VC<.N]C(1EA< JA29(\W9N;;J3"A=KV/EY=!#S

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end XML 8 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 9 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 10 FilingSummary.xml IDEA: XBRL DOCUMENT 3.22.2 html 1 24 1 false 0 0 false 0 false false R1.htm 100000 - Document - Document and Entity Information Sheet http://www.vervetx.com//20220720/taxonomy/role/DocumentDocumentAndEntityInformation Document and Entity Information Cover 1 false false All Reports Book All Reports d354954d8k.htm verv-20220720.xsd verv-20220720_lab.xml verv-20220720_pre.xml http://xbrl.sec.gov/dei/2021 true false JSON 12 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "d354954d8k.htm": { "axisCustom": 0, "axisStandard": 0, "contextCount": 1, "dts": { "inline": { "local": [ "d354954d8k.htm" ] }, "labelLink": { "local": [ "verv-20220720_lab.xml" ] }, "presentationLink": { "local": [ "verv-20220720_pre.xml" ] }, "schema": { "local": [ "verv-20220720.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd", "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://xbrl.sec.gov/dei/2021/dei-2021.xsd", "https://xbrl.sec.gov/naics/2021/naics-2021.xsd" ] } }, "elementCount": 25, "entityCount": 1, "hidden": { "http://xbrl.sec.gov/dei/2021": 2, "total": 2 }, "keyCustom": 0, "keyStandard": 24, "memberCustom": 0, "memberStandard": 0, "nsprefix": "verv", "nsuri": "http://www.vervetx.com/20220720", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "p", "div", "div", "body", "html" ], "baseRef": "d354954d8k.htm", "contextRef": "duration_2022-07-20_to_2022-07-20", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "100000 - Document - Document and Entity Information", "role": "http://www.vervetx.com//20220720/taxonomy/role/DocumentDocumentAndEntityInformation", "shortName": "Document and Entity Information", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "p", "div", "div", "body", "html" ], "baseRef": "d354954d8k.htm", "contextRef": "duration_2022-07-20_to_2022-07-20", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 0, "tag": { "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag", "terseLabel": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.vervetx.com//20220720/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code", "terseLabel": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.vervetx.com//20220720/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]", "terseLabel": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2021", "xbrltype": "stringItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date", "terseLabel": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.vervetx.com//20220720/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "dateItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type", "terseLabel": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.vervetx.com//20220720/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "submissionTypeItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One", "terseLabel": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.vervetx.com//20220720/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine2": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 2 such as Street or Suite number", "label": "Entity Address, Address Line Two", "terseLabel": "Entity Address, Address Line Two" } } }, "localname": "EntityAddressAddressLine2", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.vervetx.com//20220720/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town", "terseLabel": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.vervetx.com//20220720/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code", "terseLabel": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.vervetx.com//20220720/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province", "terseLabel": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.vervetx.com//20220720/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key", "terseLabel": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.vervetx.com//20220720/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company", "terseLabel": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.vervetx.com//20220720/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntityExTransitionPeriod": { "auth_ref": [ "r7" ], "lang": { "en-us": { "role": { "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.", "label": "Entity Ex Transition Period", "terseLabel": "Entity Ex Transition Period" } } }, "localname": "EntityExTransitionPeriod", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.vervetx.com//20220720/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number", "terseLabel": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.vervetx.com//20220720/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "fileNumberItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation State Country Code", "terseLabel": "Entity Incorporation State Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.vervetx.com//20220720/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name", "terseLabel": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.vervetx.com//20220720/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number", "terseLabel": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.vervetx.com//20220720/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "employerIdItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number", "terseLabel": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.vervetx.com//20220720/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre Commencement Issuer Tender Offer", "terseLabel": "Pre Commencement Issuer Tender Offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.vervetx.com//20220720/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r3" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre Commencement Tender Offer", "terseLabel": "Pre Commencement Tender Offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.vervetx.com//20220720/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r0" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Security 12b Title", "terseLabel": "Security 12b Title" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.vervetx.com//20220720/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name", "terseLabel": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.vervetx.com//20220720/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r4" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material", "terseLabel": "Soliciting Material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.vervetx.com//20220720/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol", "terseLabel": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.vervetx.com//20220720/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "tradingSymbolItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r6" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications", "terseLabel": "Written Communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.vervetx.com//20220720/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" } }, "unitCount": 0 } }, "std_ref": { "r0": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b" }, "r1": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1" }, "r2": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c" }, "r3": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b" }, "r4": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12" }, "r5": { "Name": "Regulation 12B", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2" }, "r6": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425" }, "r7": { "Name": "Securities Act", "Number": "7A", "Publisher": "SEC", "Section": "B", "Subsection": "2" } }, "version": "2.1" } ZIP 13 0001193125-22-198474-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001193125-22-198474-xbrl.zip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end